We are live on ! Find out more
TNXP icon

Tonix Pharmaceuticals
TNXP

23 hedge funds and large institutions have $11.1M invested in Tonix Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

63% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 8

28% more funds holding

Funds holding: 18 → 23 (+5)

0% more ownership

Funds ownership: 0% → 0% (+0%)

25% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 4

57% less capital invested

Capital invested by funds: $25.7M → $11.1M (-$14.6M)

Holders
23
Holders Change
+5
Holders Change %
+27.78%
% of All Funds
0.39%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
3
Reduced
4
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$3.17M
2
M
Murchinson
Ontario, Canada
+$1.84M
3
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$1.7M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$590K
5
Millennium Management
Millennium Management
New York
+$517K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$2.73M
2
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$1.15M
3
State Street
State Street
Massachusetts
-$738K
4
Geode Capital Management
Geode Capital Management
Massachusetts
-$369K
5
Northern Trust
Northern Trust
Illinois
-$369K
Name Holding Trade Value Shares
Change 		Change in
Stake
Citigroup
26
Citigroup
New York
$11K – – –
EMG
27
ETF Managers Group
New Jersey
$10K – – –
ETC
28
Exchange Traded Concepts
Oklahoma
$4K – – –
Fidelity Investments
29
Fidelity Investments
Massachusetts
$3K – – –
IA
30
IFP Advisors
Florida
$2K – – –
Legal & General Group
31
Legal & General Group
United Kingdom
$2K – – –
Osaic Holdings
32
Osaic Holdings
Arizona
$2K – – –
PNC Financial Services Group
33
PNC Financial Services Group
Pennsylvania
$2K – – –
Federated Hermes
34
Federated Hermes
Pennsylvania
$1K – – –
GRP
35
Global Retirement Partners
California
$1K – – –
NL
36
NVWM LLC
Pennsylvania
$1K – – –
FDCDDQ
37
Federation des caisses Desjardins du Quebec
Quebec, Canada
$250 – – –
D.E. Shaw & Co
38
D.E. Shaw & Co
New York
– -$1.15M -8 Closed
Bank of New York Mellon
39
Bank of New York Mellon
New York
– -$305K -2 Closed
Charles Schwab
40
Charles Schwab
California
– -$288K -2 Closed
N
41
Nuveen
North Carolina
– -$315K -2 Closed
AA
42
ALPS Advisors
Colorado
– -$117K -1 Closed
CM
43
Crestline Management
Texas
– -$82K -1 Closed
RhumbLine Advisers
44
RhumbLine Advisers
Massachusetts
– -$86K -1 Closed
Two Sigma Advisers
45
Two Sigma Advisers
New York
– -$182K -1 Closed
AllianceBernstein
46
AllianceBernstein
Tennessee
– -$23K – –
AB
47
Amalgamated Bank
New York
– -$12K – –
AIG
48
American International Group
New York
– -$57K – –
AIP
49
Ameritas Investment Partners
Nebraska
– -$6K – –
California State Teachers Retirement System (CalSTRS)
50
California State Teachers Retirement System (CalSTRS)
California
– -$50K – –
1
2
3 4

TNXP Hedge Fund Activity: Q2 2022 in Review

23 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Tonix Pharmaceuticals (TNXP) for Q2 2022, worth a combined $11.1M — down 57% from $25.7M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new TNXP positions and 8 closed out — a net gain of 5 holders — while 3 added to existing stakes and 4 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $3.17M. The largest seller was BlackRock, cutting an estimated $2.73M.

  • 23 institutional investors held Tonix Pharmaceuticals (TNXP) as of Q2 2022, up from 18 in Q1 2022.
  • Funds reported $11.1M of Tonix Pharmaceuticals stock for Q2 2022, down 57% quarter-over-quarter.
  • 13 funds opened new Tonix Pharmaceuticals positions in Q2 2022 and 8 closed out, a net change of +5 holders.
  • The largest Tonix Pharmaceuticals buyer in Q2 2022 was Morgan Stanley, an estimated $3.17M added.
  • The largest Tonix Pharmaceuticals seller in Q2 2022 was BlackRock, an estimated $2.73M sold.

Based on aggregated 13F filings for Q2 2022.